2022
|
Invention
|
Powdered formulations of cromolyn sodium and ibuprofen.
The invention is directed to a compositi... |
2021
|
Invention
|
Car-treg-based therapies targeting myelin oligodendrocyte glycoprotein (mog) for treating neurode... |
|
Invention
|
Cellular ablation of hla-class i mhc.
The invention provides compositions and methods for reduci... |
|
Invention
|
Cellular ablation of hla-class i mhc. The invention provides compositions and methods for reducin... |
2020
|
Invention
|
Treatment and prevention of dementia and other neurodegenerative diseases. The present invention ... |
2019
|
Invention
|
Powdered formulations of cromolyn sodium and alpha-lactose. 10 of 2-13 μm. The present disclosure... |
|
Invention
|
Methods of treating cytokine release syndrome.
The present disclosure relates to a method of tre... |
|
Invention
|
Methods of treating cytokine release syndrome. The present disclosure relates to a method of trea... |
|
Invention
|
Powdered formulations of cromolyn sodium and α-lactose. 90501010 of 2-13 μm. The present disclosu... |
|
Invention
|
Powdered formulations of cromolyn sodium and .alpha.-lactose. The present disclosure is directed ... |
|
Invention
|
Car-treg-based therapies for treating neurodegenerative diseases. The invention provides composit... |
2017
|
Invention
|
Cromolyn compositions and methods thereof. Methods of delivering cromolyn to a patient in need th... |
|
Invention
|
Powdered formulations of cromolyn sodium and ibuprofen. The invention is directed to a compositio... |
2016
|
Invention
|
Compositions and methods for treating ischemic stroke.
The invention is directed to methods of t... |
|
Invention
|
Compositions and methods for treating ischemic stroke. The invention is directed to methods of tr... |
|
Invention
|
Methods for treating alzheimer's disease and related disorders. The invention is directed to a me... |
2014
|
Invention
|
Methods for delivering cromolyn. Methods of delivering cromolyn to a patient in need thereof meth... |